Linked Life Data

8200363

Source:http://linkedlifedata.com/resource/pubmed/id/8200363

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1994-7-1
pubmed:abstractText
CA-125 was determined in 298 patients with ovarian carcinoma both initially, and during and after treatment. The upper limit of normal for CA-125 in our laboratory is 65 units/ml. Postoperatively, serum CA-125 antigen showed three distinct patterns: 20% of patients in whom levels fluctuate within the normal range have active disease; 100% of patients with fluctuations above 65 U/ml are found to have active disease; 100% of patients in whom levels of CA-125 increase progressively from any nadir, have active disease. An elevated concentration of CA-125 antigen indicates presence of tumor and allows avoidance of 2nd-look surgery. Serum CA-125 antigen fluctuating within the normal range does not indicate eradication of the viable tumor cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-2936
pubmed:author
pubmed:issnType
Print
pubmed:volume
14 Suppl
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
128-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Usefulness of determination of CA-125 in monitoring patients with ovarian carcinoma.
pubmed:affiliation
Department of Nuclear Medicine, Maria Sk?odowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
pubmed:publicationType
Journal Article, Comparative Study